Open Menu
PUBLICATIONS
AND PRESENTATIONS

Relevant to Our
Pipeline and Science

Scientific Presentations

January 28, 2025 I New York City, USA

The commercial potential and medical need for sozinibercept in wet AMD

Featured Speaker

Fred Guerard, PharmD, MS

Chief Executive Officer

Mike Campbell

Chief Commercial Officer

Charles C. Wykoff, MD, PhD

Co-Chair
Play Video
January 28, 2025
Opthea In-Person and Virtual Investor Day to Discuss the Commercial Potential and Medical Need for Sozinibercept in Wet Age-Related Macular Degeneration
September 21, 2024 I Barcelona, Spain

Improving on the Standard Care in nAMD: Addressing the VEGF-C and -D Pathways

Featured Speaker

Arshad M. Khanani, MD, MA, FASRS

Chief Medical Advisor
Chair of MAB

Adnan Tufail, MBBS, MD, FRCOphth

Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI

Anat Loewenstein, MD, MHA
Play Video
September 9, 2024
Euretina Symposium

Improving on the Standard of Care in nAMD: Addressing the VEGF-C and -D Pathways

 

nAMD: Where Are we Today?

 

 

Adnan Tufail, MD, MBBS, FRCOphth

April 3, 2024 I Virtual

Transforming Patient Outcomes with Superior Vision Gains

Featured Speaker

Fred Guerard, PharmD, MS

Chief Executive Officer

Arshad M. Khanani, MD, MA, FASRS

Chief Medical Advisor
Chair of MAB

Charles C. Wykoff, MD, PhD

Co-Chair

Veeral Sheth, MD, MBA, FACS
Play Video
April 3, 2024 I Virtual Event
Virtual KOL Event 2024

Transforming Patient Outcomes with Superior Vision Gains

 

Welcome

 

Fred Guerard, PharmD, MS

“Superior vision empowers individuals and their families to pursue their passions and focus on life’s brilliance. At Opthea, we are dedicated to pioneering innovation by pushing the boundaries of what’s possible to improve sight.”

Fred Gerard, PharmD
Chief Executive Officer
EXPLORE OUR PIPELINE